The Lancet. Microbe · 2027
Mechanisms underlying rheumatic heart disease immune-mediated pathogenesis: T-cell responses, cytokine networks, and immune dysregulation as drivers of valvular injury.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lupieri Adrien, Diaz Juan Manuel, Moreira Thayse Batista, Jacaúna Adriana, McCormick John K, Nizet Victor, Levine Robert A, Aikawa Elena, Dutra Walderez O, Leducq PRIMA (Preventing Rheumatic Injury bioMarker Alliance) Network
Аннотация
Acute rheumatic fever is an immune-mediated sequela of Streptococcus pyogenes (group A Streptococcus) infection, presenting with fever, arthritis, chorea, rash, and, crucially, carditis. Without effective secondary prophylaxis and care, acute rheumatic fever can progress to chronic rheumatic heart disease, a leading yet under-recognised cause of cardiovascular morbidity and death that disproportionately affects children and young adults aged 5-24 years in low-resource settings. Robust evidence implicates the role of antigenic mimicry-particularly between streptococcal M protein and cardiac or myocardial matrix proteins-together with dysregulated immune control in driving valvular injury. In this Review, we discussed mechanisms of rheumatic heart disease immunopathogenesis, highlighting the roles of T-cell responses, chemokine-guided recruitment to valves, cytokine dysregulation, endothelial activation, and stromal remodelling. We also analysed limitations of existing data and delineate strategies to develop experimental models, identify biomarkers, and define immunomodulatory targets that can inform earlier diagnosis, enhanced secondary prevention, and rational therapeutic strategies.